308 related articles for article (PubMed ID: 2570521)
1. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
Francis GS
Am Heart J; 1989 Sep; 118(3):642-8. PubMed ID: 2570521
[TBL] [Abstract][Full Text] [Related]
2. Interactions between the sympathetic nervous system and the RAAS in heart failure.
Goldsmith SR
Curr Heart Fail Rep; 2004 Jul; 1(2):45-50. PubMed ID: 16036024
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
Adams KF
Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
[TBL] [Abstract][Full Text] [Related]
4. Interrupting the adaptive changes in congestive heart failure.
Kupper W
Am J Cardiol; 1991 May; 67(12):20C-22C. PubMed ID: 1673586
[TBL] [Abstract][Full Text] [Related]
5. The control of adrenergic function in heart failure: therapeutic intervention.
Clark AL; Cleland JG
Heart Fail Rev; 2000 Mar; 5(1):101-14. PubMed ID: 16228919
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of sodium and water retention in heart failure.
Cadnapaphornchai MA; Gurevich AK; Weinberger HD; Schrier RW
Cardiology; 2001; 96(3-4):122-31. PubMed ID: 11805379
[TBL] [Abstract][Full Text] [Related]
7. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
Packer M
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac insufficiency. Current treatment].
Aumont MC; Castaigne A
Rev Prat; 1988 Feb; 38(5 Suppl):5-11. PubMed ID: 2895497
[No Abstract] [Full Text] [Related]
9. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the adrenergic and renin-angiotensin-aldosterone-systems.
van Zwieten PA; de Jonge A
Postgrad Med J; 1986; 62 Suppl 1():23-7. PubMed ID: 3534860
[TBL] [Abstract][Full Text] [Related]
11. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology and treatment of congestive heart failure--recently advanced strategy for heart failure].
Kitabatake A
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):9-18. PubMed ID: 7744373
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
Pouleur H; Hanet C; Rousseau MF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):82S-83S. PubMed ID: 2572263
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
Doughty RN; Sharpe N
Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
[TBL] [Abstract][Full Text] [Related]
15. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
Kubo SH
Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
[TBL] [Abstract][Full Text] [Related]
16. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
17. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
[TBL] [Abstract][Full Text] [Related]
19. The sympathetic nervous system and heart failure.
Zhang DY; Anderson AS
Cardiol Clin; 2014 Feb; 32(1):33-45, vii. PubMed ID: 24286577
[TBL] [Abstract][Full Text] [Related]
20. What constitutes optimal neurohumoral antagonism in chronic heart failure?
Tajik AA; Dickstein K
Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
